Open menu
Paytm Money logo
SBI Mutual Fund

SBI Healthcare Opportunities Fund Direct Plan-Dividend

NAV
returns change indicator
84.1718
as on 20 Sep 2019 09:45 PM
1.5894(1.92%)
Last Change
loaderloader
Schemes Managed By
Investment Performance
would have given a returns of
110,871
star
121,647
star
76,482
star
80,433
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
19,567
Profit (absolute return)
19.57%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
2.49%
In the last 6 months
3.78%
In the last 1 year
13.79%
In the last 3 years
19.57%
In the last 5 years
10.05%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
SBI Healthcare Opportunities Fund Direct Plan-Dividend
SBI Healthcare Opportunities Fund Direct Plan-Dividend
as of 20 Sep 2019 09:45 PM
901.67 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50% if redeemed within 15 days
1.39%
Expense Ratio
Plan
Dividend
8.93%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 0.50% if redeemed within 15 days
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Healthcare
90.66%
817.45 Cr
Cash Holding
8.93%
80.52 Cr
Construction
0.41%
3.70 Cr
Sectors Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Healthcare
90.66%
817.45 Cr
Cash Holding
8.93%
80.52 Cr
Construction
0.41%
3.70 Cr
Companies Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
12.49%
112.62 Cr
Divi's Laboratories Ltd.
9.73%
87.73 Cr
Others
8.93%
80.52 Cr
Cipla Ltd.
7.34%
66.18 Cr
Lupin Ltd.
6.78%
61.13 Cr
Alkem Laboratories Ltd.
6.05%
54.55 Cr
Strides Pharma Science Ltd.
5.44%
49.05 Cr
Torrent Pharmaceuticals Ltd.
5.11%
46.08 Cr
Ajanta Pharma Ltd.
4.54%
40.94 Cr
Aurobindo Pharma Ltd.
4.26%
38.41 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
12.49%
112.62 Cr
Divi's Laboratories Ltd.
9.73%
87.73 Cr
Others
8.93%
80.52 Cr
Cipla Ltd.
7.34%
66.18 Cr
Lupin Ltd.
6.78%
61.13 Cr
Alkem Laboratories Ltd.
6.05%
54.55 Cr
Strides Pharma Science Ltd.
5.44%
49.05 Cr
Torrent Pharmaceuticals Ltd.
5.11%
46.08 Cr
Ajanta Pharma Ltd.
4.54%
40.94 Cr
Aurobindo Pharma Ltd.
4.26%
38.41 Cr
View All
View All
About SBI Healthcare Opportunities Fund Direct Plan-Dividend
SBI Healthcare Opportunities Fund Direct Plan-Dividend is a Equity mutual fund scheme from SBI Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Tanmaya Desai. It has an AUM of ₹901.67 Crores and the latest NAV decalared is ₹84.172 as on 20 Sep 2019 at 9:45 pm.
SBI Healthcare Opportunities Fund Direct Plan-Dividend scheme return performance in last 1 year is -13.79%, in last 3 years is -19.57% and 100.47% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
AUM:901.67 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End
Scheme Objective
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
AMC Information
SBI Mutual Fund
SBI Mutual Fund
View AMC Details
321,933.58 Cr
AUM
104
Schemes
Address
Address
9th Floor-Crescenzo, C-38 & 39-G Block, Bandra-Kurla Complex,Bandra (East)400051
Phone Number
Phone Number
Phone : 022-61793000 / 1800-425-5425
Fax : 022-22189663